Efficient lentiviral transduction of human cord blood CD34+ cells followed by their expansion and differentiation into dendritic cells

Experimental Hematology

Volumn 29, Issue 10, 2001, Pages 1210-1217

  Oki, Masayuki ^b   Ando, Kiyoshi ^b   Hagihara, Masao ^b   Miyatake, Hiroko ^b   Shimizu, Takashi ^b   Miyoshi, Hiroyuki ^c   Nakamura, Yoshihiko ^b   Matsuzawa, Hideyuki ^b   Sato, Tadayuki ^b   Ueda, Yoko ^b   Gansuvd, Balgansuren ^b   Kato, Shunichi ^b   Hotta, Tomomitsu ^a  

^a Division of Hematology   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; CELL DIFFERENTIATION; COMBINED IMMUNODEFICIENCY; DENDRITIC CELL; HUMAN; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LENTIVIRINAE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSGENE; UMBILICAL CORD BLOOD; VIRUS TRANSCRIPTION;

ANTIGENS, CD; ANTIGENS, CD34; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; FETAL BLOOD; GROWTH SUBSTANCES; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; LENTIVIRUSES, PRIMATE; LEUKOCYTES, MONONUCLEAR;

EID: 0034814938     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00695-6     Document Type: Article

References (37)

1. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplanted from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources
2. Immune and hematopoietic reconstitution after transplantation of cord blood progenitor cells; case report and review of the literature
3. Umbilical cord blood T lymphocytes are induced to apoptosis after being allo-primed in vitro
4. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation
5. Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor
6. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application
7. Gene-modified dendritic cells for use in tumor vaccines
8. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors
9. + cells
10. High efficiency adenovirus-mediated gene transfer to human dendritic cells
11. Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes
12. Extensive and long-term ex vivo production of dendritic cells from CD34 positive umbilical cord blood or bone marrow cells by novel culture system using mouse stroma
13. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
14. Versatile retroviral vectors for potential use in gene therapy
15. Production of high titer helper-free retroviruses by transient transfection
16. Construction and use of a safe and efficient amphotropic packaging cell line
17. Development of a self-inactivating lentivirus vector
18. Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system
19. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor α
20. Development of lentiviral vectors for gene therapy for human diseases
21. High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions
22. High efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice
23. low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo
24. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential
25. Ex vivo expansion of human cord blood stem cells and its application to gene therapy
26. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny
27. One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus g protein pseudotyped retrovirus
28. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
29. - cells human hematopoietic cells by HIV-1-based lentiviral vectors
30. Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity
31. + cord blood cells under serum-free conditions
32. + cells
33. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic t-lymphocytes response in vitro
34. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system
35. + T cells
36. + cord blood cells in the presence of autologous cord blood plasma
37. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage-colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses